Literature DB >> 9892001

Antenatal hydronephrosis: thresholds of renal pelvic diameter to predict insignificant postnatal pelviectasis.

D R Siemens1, K A Prouse, A E MacNeily, E E Sauerbrei.   

Abstract

We tested the parameters of gestational age and renal pelvic anteroposterior (AP) diameter of antenatally detected pelvicaliectasis for their ability to determine insignificant postnatal renal pelvic dilatation. A retrospective analysis of 10,365 antenatal sonograms revealed 121 kidneys with pelvicaliectasis, from which 99 sonograms with sufficient postnatal follow-up were reviewed. Gestational ages were classified as <20, 20-30, or >30 weeks. Thresholds of renal pelvic AP diameter in each gestational period that were predictive of postnatal insignificance were determined to be <6, <8, and <10 mm, respectively. Insignificance postnatally was defined as no or minimal renal pelvic splitting (Society for Fetal Urology grade <II/IV). By categorizing the antenatal sonograms into gestational periods and varying the threshold of AP diameter in each period, the overall sensitivity, specificity, positive predictive value, and negative predictive value of these parameters were 89%, 96%, 95%, and 91%, respectively. We conclude that applying these parameters to antenatal pelvicaliectasis could ultimately provide a clinical management strategy that would aid in the prediction of an insignificant postnatal outcome and obviate unnecessary investigations, anxiety, and cost.

Entities:  

Mesh:

Year:  1998        PMID: 9892001

Source DB:  PubMed          Journal:  Tech Urol        ISSN: 1079-3259


  10 in total

1.  Ultrasound Scanning in Fetal Renal Pelvis Dilatation: not only Hydronephrosis.

Authors:  Alessandro Cavaliere; Santina Ermito; Alessia Mammaro; Angela Dinatale; Manuela Chiara Accardi; Elisa Maria Pappalardo; Stefania Recupero
Journal:  J Prenat Med       Date:  2009-10

Review 2.  Antenatal hydronephrosis.

Authors:  David M Kitchens; C D Anthony Herndon
Journal:  Curr Urol Rep       Date:  2009-03       Impact factor: 3.092

3.  Variability Over Time of Normal-Sized Fetal Renal Pelvis During the Second Trimester Scan.

Authors:  Maria Aurora Hernandez Røset; Harm-Gerd Karl Blaas; Tove Anita Fagerli; Torbjørn Moe Eggebø
Journal:  Ultrasound Int Open       Date:  2017-09-26

4.  Conversations for the future in the follow-up of antenatally diagnosed renal pelvicalyceal dilatation.

Authors:  Aniruddh V Deshpande
Journal:  Pediatr Nephrol       Date:  2020-10-07       Impact factor: 3.714

5.  Postnatal management of infants with antenatally detected hydronephrosis.

Authors:  Nejat Aksu; Onder Yavaşcan; Murat Kangin; Orhan D Kara; Yahya Aydin; Hakan Erdoğan; Tuba Cerçi Tuncel; Ergün Cetinkaya; Erkan Ozbay; Tahir G Sandikçioğlu
Journal:  Pediatr Nephrol       Date:  2005-07-16       Impact factor: 3.714

Review 6.  Current management of antenatal hydronephrosis.

Authors:  Kleiton G R Yamaçake; Hiep T Nguyen
Journal:  Pediatr Nephrol       Date:  2012-07-27       Impact factor: 3.714

Review 7.  Antenatal hydronephrosis: evaluation and outcome.

Authors:  Christopher S Cooper; Janet I Andrews; Wendy F Hansen; Jerome Yankowitz
Journal:  Curr Urol Rep       Date:  2002-04       Impact factor: 2.862

8.  Treatment of infants with ureteropelvic junction obstruction: findings from the PURSUIT network.

Authors:  Vijaya M Vemulakonda; Carter Sevick; Elizabeth Juarez-Colunga; George Chiang; Nicolette Janzen; Alison Saville; Parker Adams; Gemma Beltran; Jordon King; Emily Ewing; Allison Kempe
Journal:  Int Urol Nephrol       Date:  2021-05-04       Impact factor: 2.266

9.  Prognostic value of three-dimensional ultrasound for fetal hydronephrosis.

Authors:  Junmei Wang; Weiwen Ying; Daxing Tang; Liming Yang; Dongsheng Liu; Yuanhui Liu; Jiaoe Pan; Xing Xie
Journal:  Exp Ther Med       Date:  2015-01-05       Impact factor: 2.447

10.  Revised guidelines on management of antenatal hydronephrosis.

Authors:  A Sinha; A Bagga; A Krishna; M Bajpai; M Srinivas; R Uppal; I Agarwal
Journal:  Indian J Nephrol       Date:  2013-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.